Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M FARBER

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Cancer|December 1, 1977
The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapyN M Price, R T Hoppe, V S Constantine, et al.
Cancer Treatment Reports|April 1, 1979
Electron-beam therapy for mycosis fungoides: the Stanford University experienceR T Hoppe, R S Cox, Z Fuks, et al.
Acta Dermato-Venereologica|March 23, 1999
Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasisS P Raychaudhuri, W Y Jiang, E M Farber, et al.
Archives of Dermatology|December 1, 1987
Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasisV B Morhenn, K Pregerson-Rodan, R H Mullen, et al.
Experimental Dermatology|October 4, 2000
Is psoriasis a T-cell disease?B J Nickoloff, J M Schröder, P von den Driesch, et al.
Archives of Dermatology|June 1, 1997
Persistence of T-cell clones in psoriatic lesionsJ C Chang, L R Smith, K J Froning, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Cancer|December 1, 1977
The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapyN M Price, R T Hoppe, V S Constantine, et al.
Cancer Treatment Reports|April 1, 1979
Electron-beam therapy for mycosis fungoides: the Stanford University experienceR T Hoppe, R S Cox, Z Fuks, et al.
Acta Dermato-Venereologica|March 23, 1999
Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasisS P Raychaudhuri, W Y Jiang, E M Farber, et al.
Archives of Dermatology|December 1, 1987
Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasisV B Morhenn, K Pregerson-Rodan, R H Mullen, et al.
Experimental Dermatology|October 4, 2000
Is psoriasis a T-cell disease?B J Nickoloff, J M Schröder, P von den Driesch, et al.
Archives of Dermatology|June 1, 1997
Persistence of T-cell clones in psoriatic lesionsJ C Chang, L R Smith, K J Froning, et al.
Pageof 15